Skip to content
Insight Daily Blog

Administering Pluripotent Cells in Utero to Infants with Spina Bifida Boosts Life Outcomes, Research Shows

A groundbreaking medical trial has found that administering stem cells to unborn babies affected by spina bifida during corrective surgery may represent a "major milestone" in addressing congenital conditions.

Study Parameters and Security

The American study examined six developing infants with a severe neural tube defect. Surgeons applied placenta-derived mesenchymal stem cells to the surface of the baby's spinal cord as part of the surgical correction.

Importantly, the cell therapy proved to be secure. Doctors verified that the treatment did not lead to cancerous growths, interfere with wound healing, or impede the resolution of co-occurring hindbrain herniation.

Positive Developments

Post-birth MRI scans showed a full resolution of brainstem displacement in each of the babies. This brain structure normalization is strongly associated with better mobility and function.

"If it makes a greater number of infants capable of walking who wouldn't have, it could establish itself as the conventional approach," said the lead researcher. "The results are super exciting and open the door to a variety of prospective innovative interventions."

Future Implications and Hope

Experts not involved in the trial indicated that additional validation of these apparent benefits could signal a "new era" in fetal surgery. The possibility of ameliorating nerve function impairment occurring during fetal development is regarded as a transformative goal.

Particularly welcome would be improvements in bladder and bowel function, which are typical difficulties for individuals living with this disorder.

Looking Ahead

While this initial trial focused on a handful of cases, its safety demonstration and positive signals provide a strong foundation for larger, more comprehensive studies. The combination of regenerative medicine with proven prenatal surgical methods offers substantial hope for changing life trajectories for future generations with myelomeningocele.

About the author

Barbara Collins

A seasoned journalist with over 15 years covering UK policy and international relations, known for sharp analysis and engaging storytelling.

Insight Daily Blog

Type to search articles.